Study Reveals Altered Acetylcholine Timing Patterns in Parkinson's Disease and L-DOPA Treatment
A new preprint study using mouse models shows that dopamine loss and L-DOPA treatment alter the temporal organization of acetylcholine signaling in the striatum, not just its overall level. Researchers used fiber photometry in a standard Parkinson's disease mouse model to track acetylcholine dynamics across disease states and treatments. The findings suggest that the rhythmic timing of cholinergic signaling — not merely its quantity — may be a key, underappreciated factor in both Parkinson's disease and the involuntary movements caused by long-term L-DOPA use.
Researchers publishing on bioRxiv report that dopamine depletion in a mouse model of Parkinson's disease disrupts the slow, coordinated oscillations of acetylcholine (ACh) in the striatum, shifting activity toward irregular, higher-frequency phasic patterns. Using in vivo GRAB-ACh fiber photometry in the unilateral 6-OHDA mouse model, the team found that acute L-DOPA treatment broadly suppressed ACh activity and partially corrected this imbalance, but did not restore the underlying slow temporal structure. Chronic L-DOPA treatment, associated with established dyskinesia (involuntary movements), further degraded low-frequency ACh coordination during the drug's active period, while off-state activity retained features of the dopamine-depleted condition. Notably, amantadine — a drug used clinically to reduce L-DOPA-induced dyskinesia — restored low-frequency temporal structure both before and after L-DOPA exposure, suggesting a mechanistic link between slow ACh rhythmicity and dyskinesia. The authors argue that the temporal patterning of cholinergic interneuron activity, rather than its magnitude alone, represents a critical and previously underappreciated dimension of striatal function relevant to Parkinson's disease and its treatment complications.
What's missing
As a preprint, this study has not yet undergone peer review. The research is conducted entirely in a mouse model (unilateral 6-OHDA), and it is unclear how well these ACh dynamics translate to human Parkinson's disease. The study does not address whether restoring slow ACh oscillations — as amantadine appears to do — is sufficient on its own to prevent or reverse dyskinesia, or what the precise mechanism linking delta-band ACh disruption to abnormal movement is. The causal direction between ACh temporal disorganization and dyskinesia also remains to be established.
What different sources said
- bioRxivCenter
Altered Striatal Acetylcholine Dynamics across Dopamine Loss and L-DOPA Treatment
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.